NYSE: LRNStride Inc Stock
$143.25+1.29 (+0.91%)
Updated Jun 13, 2025
LRN Price
$143.25
Fair Value Price
N/A
Market Cap
$6.23B
52 Week Low
$63.25
52 Week High
$162.30
P/E
20.55x
P/B
4.4x
P/S
2.39x
PEG
3.24x
Dividend Yield
N/A
Revenue
$2.29B
Earnings
$299.40M
Gross Margin
39.1%
Operating Margin
17.75%
Profit Margin
13.1%
Debt to Equity
0.56
Operating Cash Flow
$307M
Beta
0.6
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
LRN Overview
Stride Incorporated is a tech-based education company that provides proprietary curriculum, software systems, and educational services to facilitate individualized learning for students in kindergarten through 12th grade in the U.S. and internationally. Stride was founded in 2000 and is headquartered in Herndon, VA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine LRN's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Education
Industry Rating
A
LRN
Ranked#12 of 28
Ranked#12 of 28
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $31.85 | A | |
| $27.63 | A | |
| $121.84 | A |
Be the first to know about important LRN news, forecast changes, insider trades & much more!
LRN News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how LRN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LRN ($143.25) is trading above its intrinsic value of $53.95, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LRN is good value based on its earnings relative to its share price (20.55x), compared to the US market average (31.36x)
P/E vs Market Valuation
LRN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more LRN due diligence checks available for Premium users.
Valuation
LRN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
20.55x
Industry
22.44x
Market
31.36x
LRN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
LRN is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
LRN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.4x
Industry
2.23x
LRN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LRN price to earnings growth (PEG)
For valuing profitable companies with growth potential
LRN is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
LRN's financial health
Profit margin
Revenue
$613.4M
Net Income
$99.3M
Profit Margin
16.2%
LRN's Earnings (EBIT) of $405.72M... subscribe to Premium to read more.
Interest Coverage Financials
LRN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.2B
Liabilities
$790.6M
Debt to equity
0.56
LRN's short-term assets ($1.51B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LRN's short-term assets ($1.51B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LRN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
LRN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$53.1M
Investing
-$17.7M
Financing
-$22.0M
LRN's operating cash flow ($306.69M)... subscribe to Premium to read more.
Debt Coverage Financials
LRN vs Education Stocks
Stride Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.